You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

bosutinib

Showing 1 - 25 of 39
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Describe Real World Use of Bosutinib inSingle Centre in Scotland

Completed
  • Myeloid Leukemia
  • Bosutinib
  • Glasgow, United Kingdom
    eatson West of Scotland Cancer Centre
May 3, 2022

NSCLC, Mesothelioma, Bladder Cancer Trial in Augusta (Bosutinib, Pemetrexed)

Completed
  • Carcinoma, Non-Small-Cell Lung
  • +7 more
  • Augusta, Georgia
    Augusta University Georgia Cancer Center
Jun 10, 2022

Metastatic Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Hormone Receptor Positive Breast Cancer

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Washington, District of Columbia
    Lombardi Comprehensive Cancer Center
Jan 17, 2022

B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

Completed
  • B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
  • +6 more
  • Bosutinib
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 25, 2022

Chronic Myeloid Leukemia Trial in Worldwide (Bosutinib, Ropeginterferon)

Recruiting
  • Chronic Myeloid Leukemia
  • Aalborg, Denmark
  • +17 more
Apr 4, 2022

Leukemia, Chronic Myelogenous Trial in Japan (Bosutinib)

Completed
Has Results
  • Leukemia, Chronic Myelogenous
  • Bosutinib
  • Toyoake-City, Aichi, Japan
  • +20 more
Apr 26, 2022

Landscape and Real-life Treatment Outcomes in Hungary: Analysis

Completed
  • Chronic Myeloid Leukaemia
  • Bosutinib
  • +4 more
  • Budapest, Hungary
    Pfizer
Dec 15, 2022

Breast Cancer Trial in Worldwide (Bosutinib, Letrozole)

Terminated
Has Results
  • Breast Cancer
  • Whittier, California
  • +10 more
Aug 31, 2021

Chronic Myeloid Leukemia Trial in Italy (Bosutinib)

Completed
  • Chronic Myeloid Leukemia
  • Bosutinib
  • Alessandria, Italy
  • +44 more
Feb 2, 2023

Safety And Efficacy Of Bosutinib

Recruiting
  • Chronic Myelogenous Leukemia
  • Bosutinib
  • Shibuya-ku, Japan
    (unnamed)
Dec 29, 2020

Amyotrophic Lateral Sclerosis Trial in Japan (Bosutinib)

Recruiting
  • Amyotrophic Lateral Sclerosis
  • Bosutinib
  • Kyoto, Japan
  • +3 more
Feb 3, 2021

Accelerated Phase Chronic Myelogenous Leukemia (CML), Blast Phase Chronic Myelogenous Leukemia (CML), Chronic Phase Phase

Terminated
  • Accelerated Phase Chronic Myelogenous Leukemia (CML)
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 17, 2020

Chronic Myelogenous Leukemia Trial in Worldwide (Asciminib, Bosutinib)

Active, not recruiting
Has Results
  • Chronic Myelogenous Leukemia
  • Chicago, Illinois
  • +87 more
Jan 20, 2023

Chronic Myeloid Leukemia, Chronic Myeloid Leukemia in Remission, BCR-ABL Positive Chronic Myelogenous Leukemia Trial in Moscow

Active, not recruiting
  • Chronic Myeloid Leukemia
  • +2 more
  • Moscow, Russian Federation
    National Research Center for Hematology
Oct 1, 2020

Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors Trial in Canada (Olaparib, Dasatinib, Nivolumab plus Ipilimumab)

Recruiting
  • Lymphoma, Non-Hodgkin
  • +2 more
  • Edmonton, Alberta, Canada
  • +9 more
Jan 9, 2023

Previously Treated PH + CML Trial in Worldwide (Bosutinib)

Terminated
Has Results
  • Previously Treated PH + CML
  • Bosutinib
  • Los Angeles, California
  • +47 more
Dec 2, 2021

Mild Cognitive Impairment, Dementia Trial in Santa Monica (bosutinib)

Enrolling by invitation
  • Mild Cognitive Impairment
  • Dementia
  • bosutinib
  • Santa Monica, California
    Neurological Associates of West LA
Feb 25, 2021

Blasts Under 15 Percent of Bone Marrow Nucleated Cells, Blasts Under 15 Percent of Peripheral Blood White Cells, Blasts Under 30

Terminated
Has Results
  • Blasts Under 15 Percent of Bone Marrow Nucleated Cells
  • +4 more
  • Bosutinib
  • Laboratory Biomarker Analysis
  • Houston, Texas
    M D Anderson Cancer Center
Apr 22, 2020

Leukemia, Myelogenous, Chronic Trial in Monza, Milano (Bosutinib, Bone Marrow Transplant, Bone Marrow cells)

Completed
  • Leukemia
  • +3 more
  • Bosutinib
  • +2 more
  • Monza, Italy/MB, Italy
  • +1 more
Nov 3, 2020

Chronic Myeloblastic Leukaemia Trial in Spain (Bosutinib)

Completed
  • Chronic Myeloblastic Leukaemia
  • Bosutinib
  • Gran Canaria, Spain
  • +12 more
Apr 28, 2020

Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive Trial in Worldwide (Imatinib, Nilotinib, Bosutinib)

Recruiting
  • Chronic Myeloid Leukemia (CML) Philadelphia Chromosome Positive
  • Longmont, Colorado
  • +128 more
Aug 1, 2022

Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Uijeongbu si (Asciminib single agent, Asciminib, Imatinib)

Recruiting
  • Chronic Myelogenous Leukemia
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  • Asciminib single agent
  • +5 more
  • Ann Arbor, Michigan
  • +49 more
Jan 26, 2023

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in United States (Bosutinib, Dasatinib, Laboratory Biomarker

Active, not recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Bosutinib
  • +5 more
  • Anchorage, Alaska
  • +540 more
Dec 14, 2022

Describe The Real World Use Of Bosutinib In The UK And

Completed
Has Results
  • Chronic Myeloid Leukaemia
  • Bosutinib
  • Liverpool, Merseyside, United Kingdom
  • +2 more
May 1, 2019

Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive Trial in Worldwide

Completed
Has Results
  • Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive
  • Anaheim, California
  • +188 more
Apr 16, 2021